Dermatologist Preferences for First-Line Therapy of Moderate-to-Severe Psoriasis in Healthy Adults

被引：0

作者：

Wan, Joy ^{[1
]}

Abuabara, Katrina ^{[1
]}

Troxel, Andrea B. ^{[1
]}

Shin, Daniel B. ^{[1
]}

Van Voorhees, Abby S. ^{[1
]}

Bebo, Bruce F., Jr. ^{[2
]}

Krueger, Gerald G. ^{[3
]}

Duffin, Kristina Callis ^{[3
]}

Gelfand, Joel M. ^{[1
]}

机构：

[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA

[2] Natl Psoriasis Fdn, Portland, OR USA

[3] Univ Utah, Sch Med, Salt Lake City, UT USA

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2011年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

261

引用

页码：S113 / S113

页数：1

共 50 条

[31] French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults [J].

Amatore, F. ;

Villani, A. -P. ;

Tauber, M. ;

Viguier, M. ;

Guillot, B. ;

Aubin, Francois ;

Bachelez, Herve ;

Beneton, Nathalie ;

Beylot-Barry, Marie ;

Jullien, Denis ;

Mahe, Emmanuel ;

Paul, Carle ;

Richard, Marie-Aleth .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (03) :464-483

[32] French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults [J].

Amatore, F. ;

Villani, A-P ;

Tauber, M. ;

Guillot, B. ;

Viguier, M. .

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2019, 146 (6-7) :429-439

[33] Tofacitinib for the treatment of moderate-to-severe psoriasis [J].

Chiricozzi, Andrea ;

Faleri, Sara ;

Saraceno, Rosita ;

Bianchi, Luca ;

Buonomo, Oreste ;

Chimenti, Sergio ;

Chimenti, Maria Sole .

EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (04) :443-455

[34] Managing Moderate-to-Severe Psoriasis in the Elderly [J].

Nicola Balato ;

Cataldo Patruno ;

Maddalena Napolitano ;

Angela Patrì ;

Fabio Ayala ;

Raffaele Scarpa .

Drugs & Aging, 2014, 31 :233-238

[35] Risankizumab in moderate-to-severe plaque psoriasis [J].

Serrano, Linda ;

Maloney, Victoria ;

Gordon, Kenneth B. .

IMMUNOTHERAPY, 2019, 11 (16) :1357-1370

[36] Managing Moderate-to-Severe Psoriasis in the Elderly [J].

Balato, Nicola ;

Patruno, Cataldo ;

Napolitano, Maddalena ;

Patri, Angela ;

Ayala, Fabio ;

Scarpa, Raffaele .

DRUGS & AGING, 2014, 31 (04) :233-238

[37] Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis [J].

María C. Ovejero-Benito ;

Ester Muñoz-Aceituno ;

Alejandra Reolid ;

Miriam Saiz-Rodríguez ;

Francisco Abad-Santos ;

Esteban Daudén .

American Journal of Clinical Dermatology, 2018, 19 :209-222

[38] Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis [J].

Ovejero-Benito, Maria C. ;

Munoz-Aceituno, Ester ;

Reolid, Alejandra ;

Saiz-Rodriguez, Miriam ;

Abad-Santos, Francisco ;

Dauden, Esteban .

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (02) :209-222

[39] Treatment of moderate-to-severe plaque psoriasis [J].

Salgo, R. ;

Thaci, D. .

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06) :701-711

[40] TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis [J].

Gisondi, Paolo ;

Geat, Davide ;

Conti, Andrea ;

Dapavo, Paolo ;

Piaserico, Stefano ;

De Simone, Clara ;

Bianchi, Luca ;

Costanzo, Antonio ;

Malagoli, Piergiorgio ;

Malara, Giovanna ;

Micali, Giuseppe ;

Naldi, Luigi ;

Offidani, Annamaria ;

Patrizi, Annalisa ;

Prignano, F. ;

Parodi, Aurora ;

Rongioletti, Franco ;

Calzavara-Pinton, Piergiacomo ;

Girolomoni, Giampiero .

EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (06) :591-598

← 1 2 3 4 5 →